Cancer cells exploit weaknesses in the natural regulation of T-cells by inducing the expression of co-inhibitory signals such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) or programmed death ligand 1 (PD-L1) on tumor-infiltrating lymphocytes. This evidence concerns the gene CD274 and neoplasm.